R&D Key Trends Shaping the Pharmaceutical Industry at PHARMAP 2026 20/04/2026 - 09:00 - 21/04/2026 - 18:00 Amsterdam
News ASH: Gilead preps filing for anito-cel on iMMagine-1 data Gilead's Kite unit has showcased three new CAR-T therapies at ASH, headed by multiple myeloma candidate anito-cel, which could launch next year.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
